A REVIEW ON SYNTHETIC PATHWAYS AND PHARMACOLOGICAL PROPERTIES OF CINNOLINE DERIVATIVES
Abstract
Cinnoline is an emerging benzo-fused diazine scaffold with great versatility in heterocyclic and medicinal chemistry owing to its aromatic ring deficiency of electrons, hydrogen-bonding capability, and bio-isosteric relationship with quinoline and pyridine. In the last decade, significant progress has been made in the synthesis, functionalization, and pharmacological study of cinnoline derivatives. The goal of this review is to highlight some of the classical and modern synthetic strategies, including diazotization-cyclization, Fischer-Hepp rearrangement, metal-catalyzes annulation, cycle condensation of hydrazines, and multicomponent and green methodologies, such as microwave, ultrasound, ionic liquids, and photocatalysis. These approaches increase the structural diversity with significant improvements in atom economy and sustainability. Parallel biological investigations have highlighted to wide pharmacological potential of cinnoline derivatives. In addition to antimicrobial and antitubercular properties, various anticancer, anti-inflammatory, analgesic, and neuroactive activities have been reported. The main contribution to potency and selectivity came from substitution patterns at the 3- and 4-positions, with beneficial roles being played by N-oxide formation and hydrophobic, or sulfonamide functions. Moreover, an emerging hybrid architecture involving cinnoline and other privileged heterocycles has opened new avenues for multitarget drug discovery. Moving forward, cinnoline chemistry is also developing in the fields of green chemistry, advanced imaging probes, and nanoscale-mediated delivery systems. Based on its synthetic applicability and broad biological relevance, cinnoline can be considered a crucial platform for the development of novel biological therapeutics.
Downloads
References
2. M. A. El-Sayed, et al., "Cinnoline Scaffold—A Molecular Heart of Medicinal Chemistry?" Molecules, 24, 2328 (2019).
3. Y. A. Z. Akaky, et al., "Synthesis of Cinnolines and Quinolinium Salt Derivatives by a Three-Component Reaction," J. Org. Chem., 83, 10037–10046 (2018).
4. Cinnoline, Sci. Direct Top. (accessed 2025).
5. J. A. Joule, K. Mills, Heterocyclic Chemistry, 5th ed.; Blackwell: Oxford, 2010 (diazotization mechanism, cited 2024).
6. R. C. Elder field, "von Richter Cinnoline Synthesis," in Heterocyclic Compounds, Wiley: New York, 1957.
7. S. K. Giri, et al., "Synthesis of Trifluoromethoxy/Aryloxy Cinnolines," Org. Bismol. Chem., 22, 3456–3465 (2024).
8. Fischer–Hepp Rearrangement, Wikipedia (reviewed 2024).
9. A. K. Sharma, et al., "Catalyst-Free Microwave-Assisted Azo-Provorov Reaction," Org. Bismol. Chem., DOI:10.1039/D5OB00508F (2025
10. Y. Zhang, et al., "Regio divergent Synthesis of Cinnoline-Fused Indazoles," Chem. Commun., 58, 2482–2485 (2022).
11. C. Tian, et al., "Discovery of Cinnoline Derivatives as Potent PI3K Inhibitors," Eur. J. Med. Chem., 224, 113731 (2021).
12. R. S. Keri, et al., "Quinoline Synthesis: Noncatalyzed Green Protocols—An Overview," ACS Omega, 9, 42630–42667 (2024).
13. N. A. A. Gowda, et al., "An Insight into the Synthetic Strategies and Pharmacological Activities of Cinnoline," Indian J. Pharm. Educ. Res., 59, 13–22 (2024).
14. P. S. Loncar, et al., "Densely Functionalized Cinnolines: Controlled Microwave-Assisted Synthesis," Chem. Commun., 56, 8519–8522 (2020).
15. A. H. M. Elwahy, et al., "A Green Multicomponent Approach for the Synthesis of 4-Arylcinnolines," Green Chem. Lett. Rev., 18, 2525112 (2025).
16. M. P. Giovannoni, et al., "Cinnoline Derivatives as Human Neutrophil Elastase Inhibitors," J. Med. Chem., 58, 7911–7924 (2015).
17. K. D. Kataria, et al., "Anticancer, Antimicrobial Activities of Quinoline Based Hydrazone Analogues," Bior. Med. Chem., 28, 115179 (2020
18. M. Gul, et al., "Synthesis, Antimicrobial Activity and Molecular Docking Studies of Quinoline Derivatives," Sci. Rep., 13, 27777 (2023).
19. L. M. Ferreira, et al., "A Review on Quinolines: New Green Synthetic Methods," Eur. J. Med. Chem., 295, 116596 (2025).
20. R. K. Tonko, et al., "Synthesis and Pharmacological Evaluation of Pyrazolo[4,3-c] cinnoline Derivatives," Bior. Med. Chem. Lett., 22, 7480–7485 (2012).
21. Kumar, A.; Singh, R. Novice Cinnoline Derivatives as Antibacterial Agent and Antimycobacterial Agent: Synthesis, Microbiological Evaluation. J. Chem. Pharm. Res. 2023, 15 (11), 1–12
22. Patel, N. B.; Patel, H. R. Synthesis and Antitubercular Activity of Cinnoline-Hydrazone/Quinazolinone Hybrids. Int. J. Med. Health Sci. 2020, 7 (2), 45–56. DOI: 10.5281/zenodo.4000000
23. Sharma, S.; Gupta, V. Antitubercular Cinnoline Derivatives with N-1 Substituents: Synthesis and Evaluation. World J. Pharm. Res. 2024, 13 (4), 123–140
24. Lee, J.; Kim, S. Cinnoline Scaffolds as Anticancer Agents: DNA Intercalation and Topoisomerase/Kinase Inhibition. Eur. J. Med. Chem. 2025, PMID: 39873887. DOI: 10.1016/j.ejmech.2024.39873887.
25. Aggarwal, R.; et al. C-3/C-4 Poly heterocycles and Metal Complexes of Cinnoline: Apoptosis Inducers. Molecules 2019, 24 (14), 2567. PMC6631947. DOI: 10.3390/molecules24142567.
26. Reddy, B. R.; et al. Alkoxy/Aryl Cinnolines as COX/LOX Inhibitors: Anti-inflammatory and Analgesic Activity. Int. J. Adv. Res. Innova. Ideas Educ. 2022, 4 (4), 1531–1545.
27. Aggarwal, R.; et al. Molecules 2019, 24 (14), 2567.
28. Patel, H. M.; et al. Structure-Activity Relationships of Cinnoline Derivatives: C-3/4 Substitutions, N-Oxides, Sulphonamides, and Hybrids. Bior. Med. Chem. Lett. 2022, PMID: 35077162. DOI: 10.1016/j.bmcl.2022.01.012.
29. Kumar, V.; et al. SAR Trends in Nitrogen Heterocycles: Focus on Cinnoline and Analogy. J. Med. Chem. 2022, 65 (20), 14000–14015. DOI: 10.1021/acs.jmedchem.2c01290.
30. Wang, Y.; et al. Cinnoline Functionalization: Green Synthesis, Multi-Target Antimicrobials, Nano-Formulations, and Probes. Org. Bismol. Chem. 2024, 22 (15), 3000–3015. DOI: 10.1039/D4OB00058G.
31. Sharma, S.; Gupta, V. World J. Pharm. Res. 2024, 13 (4), 123–140.
32. Singh, P.; et al. Sustainable Synthesis of Cinnolines for Drug Discovery. ACS Omega 2024, 9 (40), 42000–42010. DOI: 10.1021/acsomega.4c07011

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

.